Media
Here in the media centre you will find a range of resources including our latest and archived press releases, statements from our CEO, speeches and presentations, information on our social media policy, and our photo and video library.
Press releases
Grant to Help Coordinate Campaign to Train One Million Community Health Workers in sub-Saharan Africa
In an effort to broadly expand the reach of health care services in sub-Saharan Africa, GlaxoSmithKline (GSK) will contribute $750,000 to the One Million Community Health Workers Campaign.
GlaxoSmithKline awarded up to $200 million by U.S. government to develop new antibiotics
GlaxoSmithKline (GSK) plc and the Biomedical Advanced Research and Development Authority (BARDA), have agreed to a first of its kind collaboration that will support the development of several antibiotics to fight antibiotic resistance and bioterrorism.
BREO™ ELLIPTA™ gains US approval for the treatment of COPD
GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO™ ELLIPTA™ as an inhaled long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.



